Decreased T‐cell response against latent cytomegalovirus infection does not correlate with anti‐IFN autoantibodies in patients with APECED
APMIS · 2024-11 · 132 (11) · 881-887
DOI: 10.1111/apm.13458 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, online erschienen am 07.08.2024. Verfasst von Iivo Hetemäki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Polyendocrinopathies, Autoimmune, Autoantibodies, Cytomegalovirus Infections, Cytomegalovirus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland.
Abstract (Originalsprache)
Autoimmune polyendocrinopathy‐candidiasis‐ectodermal dystrophy (APECED) is an inborn error of immunity affecting both multiple endocrine organs and susceptibility to candidiasis, each with an autoimmune basis. Recently, high titer neutralizing anti‐type I interferon (IFN) autoantibodies have been linked with increased severity of SARS‐CoV‐2 and varicella zoster virus infections in APECED patients. Examining immunity against cytomegalovirus (CMV), we found a higher prevalence of anti‐CMV IgG antibodies in patients with APECED (N = 19) than in 44 healthy controls (90% vs 64%, p = 0.04); the similar difference in their IgG levels did not achieve significance (95 ± 74 vs 64 ± 35 IU/mL, ns.). In contrast, the frequency of CMV‐specific T cells was lower (804 ± 718/million vs 1591 ± 972/million PBMC p = 0.03). We saw no correlations between levels of anti‐CMV IgG and anti‐IFN antibodies in APECED patients or in a separate cohort of patients with thymoma (n = 70), over 60% of whom also had anti‐IFN antibodies. Our results suggest a dysregulated response to CMV in APECED patients and highlight immunodeficiency to viral infections as part of the disease spectrum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
- Department of Clinical Microbiology, HUS Diagnostic Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
- Department of Clinical Neurosciences, Weatherall Institute for Molecular Medicine, University of Oxford, Oxford, UK.
- Department of Medicine, Haukeland University Hospital, Bergen, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
ORCID-Profile: Iivo Hetemäki
Förderung
- Academy of Finland
Zitieren
APA
Hetemäki, I., Heikkilä, N., Peterson, P., Kekäläinen, E., Willcox, N., Anette S B, W., Jarva, H., & Arstila, T. P. (2024). Decreased T‐cell response against latent cytomegalovirus infection does not correlate with anti‐IFN autoantibodies in patients with APECED. APMIS, 132(11), 881-887. https://doi.org/10.1111/apm.13458
Vancouver
Hetemäki I, Heikkilä N, Peterson P, Kekäläinen E, Willcox N, Anette S B W, et al. Decreased T‐cell response against latent cytomegalovirus infection does not correlate with anti‐IFN autoantibodies in patients with APECED. APMIS. 2024;132(11):881-887. doi:10.1111/apm.13458
BibTeX
@article{Hetemki2024,
author = {Hetemäki, Iivo and Heikkilä, Nelli and Peterson, Pärt and Kekäläinen, Eliisa and Willcox, Nick and Anette S B, Wolff and Jarva, Hanna and Arstila, T Petteri},
title = {Decreased T‐cell response against latent cytomegalovirus infection does not correlate with anti‐IFN autoantibodies in patients with APECED},
journal = {APMIS},
year = {2024},
volume = {132},
number = {11},
pages = {881--887},
doi = {10.1111/apm.13458}
}
EUVIMED